| Structure | Chemical Name | CAS | MF |
|
N-CARBOBENZYLOXY-N,2-DIMETHYLALANINE
|
144332-60-5
|
C13H17NO4
|
|
asvatocin
|
144334-52-1
|
C41H62N12O12S2
|
|
phasvatocin
|
144334-53-2
|
C44H60N12O12S2
|
|
2-FLUORO-5-HYDROXY-L-TYROSINE HYDROCHLORIDE
|
144334-59-8
|
C9H11ClFNO4
|
|
9(10H)-Acridinone, 6-aMino-2-ethoxy-
|
144335-20-6
|
C15H14N2O2
|
|
4-Azatricyclo[2.2.1.02,6]heptane-1-carbonitrile(9CI)
|
144335-21-7
|
C7H8N2
|
|
3-fluoropropanesulfonate
|
144335-51-3
|
C3H7FO3S
|
|
YM 26734
|
144337-18-8
|
C45H62O8
|
|
5-(2-METHYL-1,3-THIAZOL-4-YL)INDOLINE
|
144340-48-7
|
C12H12N2S
|
|
4,4'-DibroMo-6,6'-diMethyl-[2,2']bipyridinyl
|
144342-45-0
|
C12H10Br2N2
|
|
Pyridine, 2-(2-methyl-1,3-butadienyl)-, (Z)- (9CI)
|
144343-88-4
|
C10H11N
|
|
Pyridine, 2-(2-methyl-1,3-butadienyl)-, (E)- (9CI)
|
144343-89-5
|
C10H11N
|
|
Pyridine, 3-(2-methyl-1,3-butadienyl)-, (Z)- (9CI)
|
144343-90-8
|
C10H11N
|
|
Pyridine, 3-(2-methyl-1,3-butadienyl)-, (E)- (9CI)
|
144343-91-9
|
C10H11N
|
|
Pyridine, 4-(2-methyl-1,3-butadienyl)-, (Z)- (9CI)
|
144343-92-0
|
C10H11N
|
|
Pyridine, 4-(2-methyl-1,3-butadienyl)-, (E)- (9CI)
|
144343-93-1
|
C10H11N
|
|
3-(benzyloxy)-N-[2-(3,4-dimethoxyphenyl)ethyl]benzamide
|
144344-73-0
|
C24H25NO4
|
|
Binodenoson
|
144348-08-3
|
C17H25N7O4
|
|
Pitch, gilsonite
|
144348-88-9
|
|
|
|
Fatty acids, tall oil, polymers with 1-amino-N-2-2-2-(2-aminoethyl)aminoethylaminoethylaminoethyl-13-(1-hydroxynonyl)-3,6,9,12-tetraazaheneicosan-21-amide, bisphenol A diglycidyl ether and tetraethylenepentamine
|
144348-89-0
|
|
|
|
Meri-5 protein
|
144349-92-8
|
|
|
|
SM30 protein
|
144350-05-0
|
|
|
|
HP-10 protein, human
|
144350-38-9
|
|
|
transcription factor TEF
|
144351-03-1
|
C49H63N20O32P5
|
|
|
HEM protein
|
144351-15-5
|
|
|
|
VMA11 protein
|
144351-54-2
|
|
|
17-acetoxy-3-(glucopyransosyl)oxy-6-methylpregn-4-en-20-one
|
144356-81-0
|
C30H46O9
|
|
Dimethyl (3-oxo-5-phenylpentan-2-yl)phosphonate
|
144358-71-4
|
C13H19O4P
|
|
6-deoxy-6-cyclo(histidyl-leucyl)cyclodextrin
|
144363-91-7
|
C216H402N16O173
|
|
9-Allyl-6-chloro-9H-purin-2-ylamine
|
144364-01-2
|
C8H8ClN5
|
|
2,4-Oxazolidinedione,3-(hydroxymethyl)-(9CI)
|
144365-55-9
|
C4H5NO4
|
|
1-Butanol,2-[(2-pyridinylthio)methyl]-(9CI)
|
144365-95-7
|
C10H15NOS
|
|
Carbamic acid, (2-nitrosophenyl)-, methyl ester (9CI)
|
144366-42-7
|
C8H8N2O3
|
|
6,7-DIHYDROXYSWAINSONINE
|
144367-16-8
|
C8H15NO5
|
|
(E)-Ethylidenesuccinic acid
|
144368-21-8
|
C6H8O4
|
|
Acetic acid, 2,2-(methylhydrazono)bis- (9CI)
|
144369-99-3
|
C5H10N2O4
|
|
2-Pentanone, 4-hydroxy-3-methylene-, (S)- (9CI)
|
144370-33-2
|
C6H10O2
|
|
thiangazole
|
144370-38-7
|
C26H29N5O2S3
|
|
EMTRICITABINE
|
144371-00-6
|
C8H10FN3O3S
|
|
(S)-2-(2-NAPHTHYL)GLYCOLIC ACID
|
144371-23-3
|
C12H10O3
|
|
3-deoxy-3-fluoroinositol 1,4,5-trisphosphate
|
144371-38-0
|
C6H14FO14P3
|
|
1-(1Z-octadecenyl)-2-oleoyl-sn-glycero-3-phosphoethanolaMine
|
144371-68-6
|
C41H80NO7P
|
|
FR901379
|
144371-88-0
|
C51H82N8O21S
|
|
5-Oxa-2-azaspiro[3.5]nonane-8-carboxylic acid, 1,6-dioxo-, phenylMethyl ester, (4R,8R)-rel-
|
144373-56-8
|
C15H15NO5
|
|
5-Oxa-2-azaspiro[3.5]nonane-8-carboxylic acid, 1,6-dioxo-, phenylMethyl ester, (4R,8S)-rel-
|
144373-57-9
|
C15H15NO5
|
|
5-Oxa-2-azaspiro[3.5]nonane-8-carboxylic acid, 1,6-dioxo-, (4R,8R)-rel-
|
144373-58-0
|
C8H9NO5
|
|
5-Oxa-2-azaspiro[3.5]nonane-8-carboxylic acid, 1,6-dioxo-, (4R,8S)-rel-
|
144373-59-1
|
C8H9NO5
|
|
N,N'-bis[(tert-butyloxy)carbonyl]-L-hoMocystine diMethyl ester
|
144373-70-6
|
C20H36N2O8S2
|
|
(E)-tert-Butyl 3-(4-formylphenyl)acrylate
|
144374-53-8
|
C14H16O3
|
|
glisoprenin A
|
144376-62-5
|
C45H82O5
|
|
glisoprenin B
|
144376-63-6
|
C45H82O6
|
|
|
LINOLEAMIDOPROPY L PG-DIMONIUM CHLORIDE PHOSPHATE
|
144377-73-1
|
|
|
HEPTAKIS(2,6-DI-O-METHYL-3-O-''PENTYL)-BETA-CYCLODEXTRIN*
|
144379-20-4
|
C91H168O35
|
|
napsamycin C
|
144379-26-0
|
C39H50N8O12S
|
|
napsamycin D
|
144379-27-1
|
C40H52N8O12S
|
|
1H-1,2,4-Triazole-3-carboxylic acid, 5-hydrazino-, hydrazide (9CI)
|
144382-24-1
|
C3H7N7O
|
|
poly(oligo)(3-deoxyglycero-galacto-nonulosonate)
|
144383-50-6
|
C9H16O9
|
|
Pyrimidine, 2,5-dimethyl-, radical ion(1+) (9CI)
|
144384-91-8
|
C6H8N2
|
|
1-(3-bromopropyl)-1H-imidazole(SALTDATA: HBr)
|
144385-79-5
|
C6H9BrN2
|
|
2-Nitro-7-fluoranthenol
|
144386-82-3
|
C16H9NO3
|
|
C-terminally located anterior lobe peptide, Lymnaea stagnalis
|
144387-61-1
|
C153H235N41O62S2
|
|
|
DIETHYLDICARBOCYANINE IODIDE
|
144388-17-0
|
|
|
|
DNTTCI
|
144388-20-5
|
C14H28O6
|
|
4-diphenylacetoxy-1,1-dimethylcyclohexane
|
144396-37-2
|
C22H26O2
|
|
cholecystokinin-J
|
144396-38-3
|
C49H66N6O16S
|
|
MBOTAD PRECURSOR
|
144397-34-2
|
C16H12N4O4
|
|
4-(4-PYRIDINYL)BENZONITRILE
|
144397-70-6
|
C12H8N2
|
|
obscurolide A1
|
144397-99-9
|
C15H17NO5
|
|
obscurolide A2
|
144398-00-5
|
C15H17NO4
|
|
obscurolide A3
|
144398-01-6
|
C15H19NO4
|
|
obscurolide A4
|
144398-02-7
|
C16H21NO4
|
|
acaterin
|
144398-20-9
|
C13H22O3
|
|
glutaryl-alanyl-alanyl-phenylalanyl-amidomethylcoumarin
|
144398-31-2
|
C30H34N4O8
|
|
8-(7-Hydroxy-3,7-diMethyl-2,5-octadienyloxy)psoralen
|
144398-34-5
|
C21H22O5
|
|
1,3-bis(3-methyl-5-oxo-2,6-diazabicyclo[5.4.0]undeca-7,9,11-trien-2-yl )propane-1,3-dione
|
144400-96-4
|
C23H24N4O4
|
|
ethyl 5-methyl-3-phenyl-2-[(E)-3-phenylprop-2-enoyl]-2,6-diazabicyclo[ 5.4.0]undeca-7,9,11-triene-5-carboxylate
|
144401-01-4
|
C28H28N2O3
|
|
1,2-bis(3-methyl-5-oxo-2,6-diazabicyclo[5.4.0]undeca-7,9,11-trien-2-yl )ethane-1,2-dione
|
144401-04-7
|
C22H22N4O4
|
|
(6-DIMETHYLSULFAMOYL-3-OXO-1,3-DIHYDRO-ISOBENZOFURAN-1-YL)-ACETIC ACID
|
144402-61-9
|
C12H13NO6S
|
|
Benzoic acid, 2-(propylamino)-, methyl ester (9CI)
|
144402-90-4
|
C11H15NO2
|
|
CHEMBRDG-BB 4101363
|
144402-92-6
|
C13H11N3
|
|
1,3-Dioxane-2-carboxaldehyde, 2,4-dimethyl-, (2R-trans)- (9CI)
|
144404-96-6
|
C7H12O3
|
|
1,3-Dioxane-2-carboxaldehyde, 2,4-dimethyl-, (2S-cis)- (9CI)
|
144404-98-8
|
C7H12O3
|
|
N(3)-phenacyluridine
|
144405-50-5
|
C17H18N2O7
|
|
baimuxinol methyl ether
|
144407-45-4
|
C16H28O2
|
|
10,11-Dihydro-10-hydroxycarbamazepine O--D-Glucuronide
|
144407-84-1
|
C21H22N2O8
|
|
napsamycin B
|
144408-86-6
|
C40H50N8O12S
|
|
|
AMYLOID BETA-PROTEIN (1-40) (MOUSE, RAT)
|
144409-98-3
|
C190H291N51O57S
|
|
AMYLOID BETA-PROTEIN (40-1)
|
144409-99-4
|
C194H295N53O58S
|
|
(Gln22)-Amyloid β-Protein (1-40)
|
144410-00-4
|
C21H32O2
|
|
lamifiban
|
144412-49-7
|
C24H28N4O6
|
|
|
ROSIN, REACTION PRODUCTS WITH ACRYLIC ACID, HYDROGENATED
|
144413-22-9
|
|
|
1,4,6-ANDROSTATRIEN-3,17-DIONE
|
144413-58-1
|
C18H10S2
|
|
|
receptor-like protein tyrosine phosphatase mu
|
144416-03-5
|
|
|
|
LMP-2 protein
|
144416-78-4
|
|
|
|
pancreatitis-associated protein
|
144416-83-1
|
|
|
|
GL1 protein
|
144417-31-2
|
|
|
|
A9 protein
|
144419-45-4
|
|
|
4-benzyl-3-((1-methoxy-5-methylcyclohexen-4-yl)carbonyl)-2-oxazolidinone
|
144424-76-0
|
C19H23NO4
|
|
Psycholeine
|
144424-79-3
|
C44H50N8
|
|
3-O-(E)-p-Coumaroylbetulin
|
144424-80-6
|
C39H56O4
|